Ethylcellulose, polycaprolactone, and eudragit matrices for controlled release of piroxicam from tablets and microspheres

[1] Arshady, R. (1993). Microcapsules for food. Journal of Microencapsulation, 10, 413–435. DOI: 10.3109/0265dy2049309015320. http://dx.doi.org/10.3109/02652049309015320Search in Google Scholar

[2] Belarbi, L., Boudouaia, N., & Mesli, A. (2009). Synthese et caracterisation de poly(ɛ-caprolactone) a partir d’ɛ-caprolactone et differents diacides. Physical and Chemical News, 46, 104–110. Search in Google Scholar

[3] Casas, M., Ferrero, C., & Jiménez-Castellanos, M. R. (2010). Graft tapioca starch copolymers as novel excipients for controlled-release matrix tablets. Carbohydrate Polymers, 80, 71–77. DOI: 10.1016/j.carbpol.2009.10.065. http://dx.doi.org/10.1016/j.carbpol.2009.10.06510.1016/j.carbpol.2009.10.065Search in Google Scholar

[4] Chung, T. W., Huang, Y. Y., & Liu, Y. Z. (2001). Effects of the rate of solvent evaporation on the characteristics of drug loaded PLLA and PDLLA microspheres. International Journal of Pharmaceutics, 212, 161–169. DOI: 10.1016/s0378-5173(00)00574-3. http://dx.doi.org/10.1016/S0378-5173(00)00574-310.1016/S0378-5173(00)00574-3Search in Google Scholar

[5] De Brabander, C., Vervaet, C., & Remon, J. P. (2003). Development and evaluation of sustained release mini-matrices prepared via hot melt extrusion. Journal of Controlled Release, 89, 235–247. DOI: 10.1016/s0168-3659(03)00075-0. http://dx.doi.org/10.1016/S0168-3659(03)00075-010.1016/S0168-3659(03)00075-0Search in Google Scholar

[6] Duarte, A. R. C., Costa, M. S., Simplício, A. L., Cardoso, M. M., & Duarte, C. M. M. (2006). Preparation of controlled release microspheres using supercritical fluid technology for delivery of anti-inflammatory drugs. International Journal of Pharmaceutics, 308, 168–174. DOI: 10.1016/j.ijpharm.2005.11.012. http://dx.doi.org/10.1016/j.ijpharm.2005.11.01210.1016/j.ijpharm.2005.11.012Search in Google Scholar

[7] El Bahri, Z., & Taverdet, J. L. (2007). Preparation and optimization of 2,4-D loaded cellulose derivatives microspheres by solvent evaporation technique. Journal of Applied Polymer Science, 103, 2742–2751. DOI: 10.1002/app.25488. http://dx.doi.org/10.1002/app.2548810.1002/app.25488Search in Google Scholar

[8] Freiberg, S., & Zhu, X. X. (2004). Polymer microspheres for controlled drug release. International Journal of Pharmaceutics, 282, 1–18. DOI: 10.1016/j.ijpharm.2004.04.013. http://dx.doi.org/10.1016/j.ijpharm.2004.04.01310.1016/j.ijpharm.2004.04.013Search in Google Scholar

[9] Fujimori, J., Yonemochi, E., Fukuoka, E., & Terada, K. (2002). Application of Eudragit RS to thermo-sensitive drug delivery systems. I. Thermo-sensitive drug release from acetaminophen matrix tablets consisting of Eudragit RS/PEG 400 blend polymers. Chemical & Pharmaceutical Bulletin, 50, 408–412. DOI: 10.1248/cpb.50.408. http://dx.doi.org/10.1248/cpb.50.40810.1248/cpb.50.408Search in Google Scholar

[10] Higuchi, T. (1963). Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. Journal Pharmaceutical Sciences, 52, 1145–1149. DOI: 10.1002/jps.2600521210. http://dx.doi.org/10.1002/jps.260052121010.1002/jps.2600521210Search in Google Scholar

[11] Jain, V., Jain, D., & Singh, R. (2011). Factors affecting the morphology of eudragit S-100 based microsponges bearing dicyclomine for colonic delivery. Journal of Pharmaceutical Sciences, 100, 1545–1552. DOI: 10.1002/jps.22360. http://dx.doi.org/10.1002/jps.2236010.1002/jps.22360Search in Google Scholar

[12] Khan, M. A., & Reddy, I. K. (1997). Development of solid oral dosage forms with acrylate polymers. S.T.P Pharma Sciences, 7, 483–490. Search in Google Scholar

[13] Kibbe, A. H. (2000). Handbook of pharmaceutical excipients. Washington, DC, USA: American Pharmaceutical Association. Search in Google Scholar

[14] Korsmeyer, R. W., Gurny, R., Doelker, E., Buri, P., & Peppas, N. A. (1983). Mechanisms of solute release from porous hydrophilic polymers. International Journal of Pharmaceutics, 15, 25–35. DOI: 10.1016/0378-5173(83)90064-9. http://dx.doi.org/10.1016/0378-5173(83)90064-910.1016/0378-5173(83)90064-9Search in Google Scholar

[15] Lai, M. K., & Tsiang, R. C. C. (2004). Encapsulating acetaminophen into poly(l-lactide) microcapsules by solvent evaporation technique in an O/W emulsion. Journal of Microencapsulation, 21, 307–316. DOI: 10.1080/02652040410001673928. http://dx.doi.org/10.1080/0265204041000167392810.1080/02652040410001673928Search in Google Scholar

[16] Le Corre, P. Le Guevello, P., Gajan, V., Chevanne, F., & Le Verge, R. (1994). Preparation and characterization of bupivacaine-loaded polylactide and polylactide-co-glycolide microspheres. International Journal of Pharmaceutics, 107, 41–49, DOI: 10.1016/0378-5173(94)90300-X. http://dx.doi.org/10.1016/0378-5173(94)90300-X10.1016/0378-5173(94)90300-XSearch in Google Scholar

[17] Mao, Z., Wang, B., Ma, L., Gao, C., & Shen, J. (2007). The influence of polycaprolactone coating on the internalization and cytotoxicity of gold nanoparticles. Nanomedicine: Nanotechnology, Biology, and Medicine, 3, 215–223. DOI: 10.1016/j.nano.2007.04.001. http://dx.doi.org/10.1016/j.nano.2007.04.00110.1016/j.nano.2007.04.001Search in Google Scholar PubMed

[18] Moldenhauer, M. G., & Nairn, J. G. (1990). Formulation parameters affecting the preparation and properties of microencapsulated ion-exchanged resins containing theophylline. Journal of Pharmaceutical Sciences, 79, 659–666. DOI: 10.1002/jps.2600790802. http://dx.doi.org/10.1002/jps.260079080210.1002/jps.2600790802Search in Google Scholar PubMed

[19] Mourão, S. C., da Silva, C., Bresolin, T. M. B., Serra, C. H. R., & Porta, V. (2010). Dissolution parameters for sodium diclofenac-containing hypromellose matrix tablet. International Journal of Pharmaceutics, 386, 201–207. DOI: 10.1016/j.ijpharm.2009.11.022. http://dx.doi.org/10.1016/j.ijpharm.2009.11.02210.1016/j.ijpharm.2009.11.022Search in Google Scholar PubMed

[20] Musial, W., Kokol, V., & Voncina, B. (2010a). Deposition and release of chlorhexidine from non-ionic and anionic polymer matrices. Chemical Papers, 64, 346–353. DOI: 10.2478/s11696-010-0013-y. http://dx.doi.org/10.2478/s11696-010-0013-y10.2478/s11696-010-0013-ySearch in Google Scholar

[21] Musial, W., Kokol, V., & Voncina, B. (2010b). Lidocaine hydrochloride preparations with ionic and non-ionic polymers assessed at standard and increased skin surface temperatures. Chemical Papers, 64, 84–90. DOI: 10.2478/s11696-009-0089-4. http://dx.doi.org/10.2478/s11696-009-0089-410.2478/s11696-009-0089-4Search in Google Scholar

[22] Natarajan, V., Krithica, N., Madhan, B., & Sehgal, P. K. (2011). Formulation and evaluation of quercetin polycaprolactone microspheres for the treatment of rheumatoid arthritis. Journal of Pharmaceutical Sciences, 100, 195–205. DOI: 10.1002/jps.22266. http://dx.doi.org/10.1002/jps.2226610.1002/jps.22266Search in Google Scholar PubMed

[23] Patel, S. N., Prajapati, P. H., Patel, C. N., Patel, C. M., & Patel, T. D. (2010). Formulation and development of enteric coated tablets of prednisolone as colon targeted drug delivery. Journal of Global Pharma Technology, 2, 128–132. Search in Google Scholar

[24] Phutane, P., Shidhaye, S., Lotlikar, V., Ghule, A., Sutar, S., & Kadam, V. (2010). In vitro evaluation of novel sustained release microspheres of glipizide prepared by the emulsion solvent diffusion-evaporation method. Pharmaceutics, 2, 35–41. DOI: 10.4103/0975-1483.62210. 10.4103/0975-1483.62210Search in Google Scholar PubMed PubMed Central

[25] Piao, M. G., Yang, C. W., Li, D. X., Kim, J. O., Jang, K. Y., Yoo, B. K., Kim, J. A., Woo, J. S., Lyoo, W. S., Han, S. S, Lee, Y. B., Kim, D. D., Yong, C. S., & Choi, H. G. (2008). Preparation and in vivo evaluation of piroxicam-loaded gelatin microcapsule by spray drying technique. Biological and Pharmaceutical Bulletin, 31, 1284–1287. DOI: 10.1248/bpb.31.1284. http://dx.doi.org/10.1248/bpb.31.128410.1248/bpb.31.1284Search in Google Scholar PubMed

[26] Prestwich, G. D., & Luo, Y. (2001). Novel biomaterials for drug delivery. Expert Opinion on Therapeutic Patents, 11, 1395–1410. DOI: 10.1517/13543776.11.9.1395. http://dx.doi.org/10.1517/13543776.11.9.139510.1517/13543776.11.9.1395Search in Google Scholar

[27] Puthli, S., & Vavia, P. R. (2009). Stability studies of microparticulate system with piroxicam as model drug. AAPS Pharm-SciTech, 10, 872–880. DOI: 10.1208/s12249-009-9280-8. http://dx.doi.org/10.1208/s12249-009-9280-810.1208/s12249-009-9280-8Search in Google Scholar

[28] Rajesh, N., & Siddaramaiah (2010). Design and evaluation of controlled release of piroxicam from the pellets of microcrystalline cellulose and hydroxypropylmethyl cellulose blends. International Journal of PharmTech Research, 2, 1465–1473. Search in Google Scholar

[29] Rogalsky, V., & Todorov, I. N. (2012). Drug information portal. Retreived May 20, 2011, from http://www.druglib.com/druginfo/piroxicam/description_pharmacology/ Search in Google Scholar

[30] Sahoo, S., Sasmal, A., Sahoo, D., & Nayak, P. (2010). Synthesis and characterization of chitosan-polycaprolactone blended with organoclay for control release of doxycycline. Journal of Applied Polymer Science, 118, 3167–3175. DOI: 10.1002/app.32474. http://dx.doi.org/10.1002/app.3247410.1002/app.32474Search in Google Scholar

[31] Sastry, S. V., Nyshadham, J. R., & Fix, J. A. (2000). Recent technological advances in oral drug delivery — a review. Pharmaceutical Science & Technology Today, 3, 138–145. DOI: 10.1016/s1461-5347(00)00247-9. http://dx.doi.org/10.1016/S1461-5347(00)00247-910.1016/S1461-5347(00)00247-9Search in Google Scholar

[32] Tsuji, K. (1998). Recent trends in pesticide formulations. In C. L. Foy, D. W. Pritchard, & G. B. Beestman (Eds.), Formulation Science: Proceedings from Formulation Forum’ 97 (pp. 53–83). Hattiesburg, MS, USA: The Association of Formulation Chemists. Search in Google Scholar

[33] Vlaia, L., Vlaia, V., Miclea, L. M., Olariu, I., & Coneac, G. (2009). Topical W/O/W double emulsions of piroxicam: In vitro drug release study. Farmacia, 57, 639–647. Search in Google Scholar

[34] Wade, A., & Weller, P. J. (1994) Handbook of pharmaceutical excipients (2nd ed.). Washington, DC, USA: Pharmaceutical Press. Search in Google Scholar

[35] Wang, S. H., Zhang, L. C., Lin, F., Sa, X. Y., Zuo, J. B., Shao, Q. X., Chen, G. S., & Zeng, S. (2005). Controlled release of levonorgestrel from biodegradable poly(d,l-lactide-co-glycolide) microspheres: In vitro and in vivo studies. International Journal of Pharmaceutics, 301, 217–225. DOI: 10.1016/j.ijpharm.2005.05.038. http://dx.doi.org/10.1016/j.ijpharm.2005.05.03810.1016/j.ijpharm.2005.05.038Search in Google Scholar PubMed

[36] Wen, H., & Park, K. (2010). Oral controlled release formulation design and drug delivery. New Jersey, NJ, USA: Wiley. http://dx.doi.org/10.1002/978047064048710.1002/9780470640487Search in Google Scholar